Primary cardiac lymphoma evaluated with integration of PET/CT and contrast-enhanced CT

Clinical Nuclear Medicine

Volumn 34, Issue 5, 2009, Pages 298-301

  Su, Hung Yi ^a   Huang, Han Luen ^a   Sun, Chen Ming ^a   Hou, Shaw Ming ^a   Chen, Meng Ling ^a,b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Contrast enhanced CT; F 18 FDG PET CT; Primary cardiac lymphoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; FLUORODEOXYGLUCOSE F 18; RITUXIMAB; CONTRAST MEDIUM; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CASE REPORT; COMPLETE HEART BLOCK; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG UPTAKE; ECHOCARDIOGRAPHY; ENDOCARDIAL BIOPSY; HEART TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; PRIMARY TUMOR; SYNCOPE; ATRIOVENTRICULAR BLOCK; HEART ATRIUM; HEART VENTRICLE SEPTUM; LYMPH NODE; PATHOLOGY; PLEURA; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

ADULT; ATRIOVENTRICULAR BLOCK; CONTRAST MEDIA; FLUORODEOXYGLUCOSE F18; HEART ATRIA; HEART NEOPLASMS; HEART SEPTUM; HUMANS; LYMPH NODES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; PLEURA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYNCOPE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67849097404     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31819e527c     Document Type: Article

References (12)

1. Karantanis D, O'Neill BP, Subramaniam RM, et al. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Clin Nucl Med. 2007;32:271-274.
2. Bural GG, Shriaknthan S, Houseni M, et al. FDG-PET is useful in staging and follow-up of primary uterine cervical lymphoma. Clin Nucl Med. 2007;32: 748-750.
3. Chamroonrat W, Houseni M, Bing Z, et al. Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET. Clin Nucl Med. 2007;32: 252-254.
4. Lin EC. FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med. 2007;32:152-153.
5. Kumar R, Xiu Y, Mavi A, et al. FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clin Nucl Med. 2005;30:222-230.
6. Mantzarides M, Papathanassiou D, Bonardel G, et al. High-grade lymphoma of the bladder visualized on PET. Clin Nucl Med. 2005;30:478-480.
7. Kumar R, Xiu Y, Dhurairaj T, et al. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast. Clin Nucl Med. 2005;30:246-248.
8. Bhargava P, Glass E, Brown J, et al. FDG PET in primary effusion lymphoma (PEL) of the pericardium. Clin Nucl Med. 2006;31:18-19.
9. McAllister HA, Fenoglio JJ. Tumors of the cardiovascular system. In: Atlas of Tumor Pathology. Vol Fascicle 15. Washington, DC: Armed Forces Institute of Pathology; 1978:99 -100.
10. Cairns P, Butany J, Fulop J, et al. Cardiac presentation of non-Hodgkin's lymphoma. Arch Pathol Lab Med. 1987;111:80-83.
11. Konety SH, Wooldridge JE, Kerber RE. Primary cardiac non-Hodgkin's lymphoma diagnosed by transthoracic echocardiography. Echocardiography. 2006;23:147-148.
12. Butany J, Nair V, Naseemuddin A, et al. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6:219-228.